Hematopoietic Stem Cell Donors' Experiences of Information and Side-Effects During the First Year After Donation-A

Annika M Kisch1,2, Jeanette Winterling3,4, Hans Hägglund5

  • 1Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.

PubMed

Insights

Hematopoietic stem cell (HSC) donors generally report positive experiences, with most side effects resolving quickly. Enhanced information on potential severe side effects may improve donor satisfaction.

Area of Science:

  • Hematology
  • Transplantation Medicine
  • Donor Health

Background:

  • Understanding hematopoietic stem cell (HSC) donor experiences is crucial for recruitment and retention.
  • Focus on donor information and side effects during the first year post-donation is essential.

Purpose of the Study:

  • To describe the experiences of HSC donors, specifically regarding information received and side effects encountered.
  • To evaluate donor satisfaction in relation to information and adverse events within the first year after donation.

Main Methods:

  • Prospective Swedish cohort study of adult HSC donors (2019-2022).
  • Utilized questionnaires at four time points: pre-donation to 12 months post-donation.
  • Included 173 unrelated and 68 related donors, with most donating peripheral blood stem cells.

Main Results:

  • Over 83% of donors reported at least one side effect, typically resolving within 2 weeks.
  • All but one donor rated their experience as good or very good.
  • Lower satisfaction with information and donation was noted among donors experiencing severe side effects or those donating via bone marrow or unrelated donation.

Conclusions:

  • Current donor follow-up protocols appear adequate, with a need for individualized follow-up for persistent symptoms.
  • Enhanced pre-donation information regarding the risk of severe or prolonged side effects is recommended.
  • Further evaluation of enhanced information's impact on donor satisfaction is warranted.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
495
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K